Health

The New England Journal of Medicine (NEJM) has recently announced a change in its policy regarding embargoed access to its journal articles. According to Dawn Peters, director of strategic communications & media relations at NEJM Group, news outlets targeting physician readers will no longer have access to embargoed articles. This decision has caused some controversy
0 Comments
A groundbreaking treatment candidate for amyotrophic lateral sclerosis (ALS) has shown promising results in the phase IIb PARADIGM trial. PrimeC, a unique formulation of the FDA-approved drugs ciprofloxacin and celecoxib, demonstrated positive safety outcomes and potential efficacy in ALS patients. The trial, presented by Dr. Merit Cudkowicz of Massachusetts General Hospital at the American Academy
0 Comments
Viltolarsen (Viltepso) has shown promise in the treatment of Duchenne muscular dystrophy (DMD) in boys and men, as evidenced by the results of the open-label, phase II Galactic53 trial. The therapy, which involves exon skipping, demonstrated favorable safety profiles and potential clinical benefits in pulmonary function among participants, as reported during a late-breaking poster session
0 Comments
Dallas anesthesiologist Raynaldo Rivera Ortiz Jr., MD, made headlines after being convicted for a tragic incident involving the injection of a nerve-blocking agent and other drugs into IV bags. This reckless act led to a coworker’s death and multiple cardiac emergencies among patients, bringing to light the serious consequences of medical malpractice. In a separate
0 Comments
The world of healthcare is constantly evolving, with new challenges and advancements shaping the landscape. Healthcare professionals from various fields have recently shared their critical statements on different aspects of the industry, shedding light on issues that impact patient care and medical practice. Despite the emergence of newer, highly effective cholesterol-lowering drugs, experts like Christie
0 Comments
Republican lawmakers expressed discontent during a recent hearing with FDA Commissioner Robert Califf regarding the agency’s handling of various issues, including the authorization of COVID-19 vaccines. Rep. Paul Gosar criticized the FDA for granting emergency use authorization for the COVID-19 vaccines, stating that they do not stop virus transmission and have been linked to adverse
0 Comments
Pancreatic cancer is a devastating disease with limited treatment options and poor survival rates. It is particularly challenging when the cancer is borderline resectable, meaning that the tumor is technically able to be removed surgically, but with a high risk of the cancer returning due to positive margins. In a recent pilot study presented at
0 Comments